Sale!

EPM2A Gene Myoclonic Epilepsy of Lafora Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EPM2A gene myoclonic epilepsy of Lafora genetic test is a specialized diagnostic procedure designed to identify mutations in the EPM2A gene, which are known to cause Lafora disease. Lafora disease is a rare, autosomal recessive disorder characterized by the presence of Lafora bodies (abnormal glycogen inclusions) within cells, leading to progressive myoclonus epilepsy. This condition typically manifests in late childhood or adolescence, resulting in seizures, muscle spasms, and neurological decline.

The test is crucial for early diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans that can potentially slow the disease’s progression and improve the quality of life for affected individuals. It involves collecting a DNA sample, usually through a blood draw, which is then analyzed in the laboratory for specific mutations in the EPM2A gene.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test for EPM2A gene myoclonic epilepsy of Lafora is priced at 4400 AED. The laboratory is equipped with advanced technology and staffed by experts in genetic diagnostics, ensuring high accuracy and reliability of the test results. Opting for this test at DNA Labs UAE provides patients and their families with crucial information for managing Lafora disease, supported by the lab’s commitment to excellence in genetic analysis and customer care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test

At DNA Labs UAE, we offer the EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test for individuals who may be at risk for this condition. This test can provide important information for diagnosis, genetic counseling, family planning, and potential treatment options.

Test Components

The EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test includes:

  • NGS Technology
  • Neurological Disorders
  • Genetics

Price

The cost of the EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test is 4400.0 AED.

Sample Condition

We accept the following sample conditions for this test:

  • Blood
  • Extracted DNA
  • One drop Blood on FTA Card

Report Delivery

Once the sample is received, the report will be delivered within 3 to 4 weeks.

Method

The EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test is performed using NGS (Next-Generation Sequencing) technology.

Test Type

This test is specifically designed for the diagnosis of neurological disorders, including myoclonic epilepsy of Lafora (MEOL).

Doctor

This test is recommended by a neurologist.

Test Department

The EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the EPM2A Gene Myoclonic epilepsy of Lafora NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by MEOL.

Test Details

The EPM2A gene is associated with myoclonic epilepsy of Lafora (MEOL), a rare and progressive form of epilepsy characterized by seizures, myoclonus (sudden muscle jerks), and cognitive decline. MEOL is caused by the accumulation of abnormal proteins known as Lafora bodies in the brain.

NGS genetic testing, such as the EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test, allows for the simultaneous analysis of multiple genes associated with MEOL. This test can identify mutations or variants in the EPM2A gene that may be responsible for the development of the condition. It can confirm a diagnosis of MEOL, provide important information for genetic counseling, family planning, and potential treatment options. It can also be used for carrier testing in individuals with a family history of MEOL.

It is crucial to consult with a healthcare professional or genetic counselor for further information and guidance regarding NGS genetic testing for MEOL and the interpretation of test results.

Test Name EPM2A Gene Myoclonic epilepsy of Lafora Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EPM2A Gene Myoclonic epilepsy of Lafora NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EPM2A Gene Myoclonic epilepsy of Lafora
Test Details

The EPM2A gene is associated with a type of epilepsy called myoclonic epilepsy of Lafora (MEOL). MEOL is a rare, progressive form of epilepsy characterized by seizures, myoclonus (sudden muscle jerks), and cognitive decline. It is caused by the accumulation of abnormal proteins called Lafora bodies in the brain.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes associated with a particular condition. In the case of MEOL, NGS genetic testing can be used to identify mutations or variants in the EPM2A gene that may be responsible for the development of the condition.

NGS genetic testing can help confirm a diagnosis of MEOL and provide important information for genetic counseling, family planning, and potential treatment options. It may also be used for carrier testing in individuals with a family history of MEOL.

It is important to consult with a healthcare professional or genetic counselor for further information and guidance regarding NGS genetic testing for MEOL and the interpretation of test results.